13 Jul 2024

Press & news

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

New exchange: Nasdaq First North

Calendar &
upcoming reports

29 August 2024

Q2 report 2024

28 November 2024

Q3 report 2024

27 February 2025

Annual report 2024

Show all posts